Literature DB >> 29249241

Constrained cell penetrating peptides.

S A Bode1, D W P M Löwik2.   

Abstract

In this review we provide an overview of recent developments in the field of cell penetrating peptides (CPPs) on research that aims to achieve better control over their transduction properties - one of the big challenges - by means of restraining them. Three different constraining strategies are presented: triggerable activation, backbone rigidification and macrocyclization. Each of these methods have their opportunities in gaining control over CPP activity and selectivity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2017        PMID: 29249241     DOI: 10.1016/j.ddtec.2017.11.005

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  6 in total

1.  Different Approaches to Cyclize a Cell-Penetrating Peptide and to Tether Bioactive Payloads.

Authors:  Lucia Feni; Ines Neundorf
Journal:  Methods Mol Biol       Date:  2022

2.  Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.

Authors:  Marina Buyanova; Ashweta Sahni; Rui Yang; Amar Sarkar; Heba Salim; Dehua Pei
Journal:  Mol Pharm       Date:  2022-04-11       Impact factor: 5.364

3.  Topoisomerases inhibition and DNA binding mode of daunomycin-oligoarginine conjugate.

Authors:  Valeria Visone; Ildikó Szabó; Giuseppe Perugino; Ferenc Hudecz; Zoltán Bánóczi; Anna Valenti
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 4.  Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging.

Authors:  Mengping Liu; Lin Wang; Young Lo; Simon Chi-Chin Shiu; Andrew B Kinghorn; Julian A Tanner
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

5.  Tuning of Peptide Cytotoxicity with Cell Penetrating Motif Activatable by Matrix Metalloproteinase-2.

Authors:  Jeonghun Lee; Eun-Taex Oh; Hae-June Lee; Eunkyoung Lee; Ha Gyeong Kim; Heon Joo Park; Chulhee Kim
Journal:  ACS Omega       Date:  2022-08-16

Review 6.  Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives.

Authors:  Carla Lucia Esposito; Silvia Catuogno; Gerolama Condorelli; Paola Ungaro; Vittorio de Franciscis
Journal:  Genes (Basel)       Date:  2018-10-31       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.